1. Home
  2. HWKN vs FOLD Comparison

HWKN vs FOLD Comparison

Compare HWKN & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HWKN
  • FOLD
  • Stock Information
  • Founded
  • HWKN 1938
  • FOLD 2002
  • Country
  • HWKN United States
  • FOLD United States
  • Employees
  • HWKN N/A
  • FOLD N/A
  • Industry
  • HWKN Specialty Chemicals
  • FOLD Biotechnology: Pharmaceutical Preparations
  • Sector
  • HWKN Consumer Discretionary
  • FOLD Health Care
  • Exchange
  • HWKN Nasdaq
  • FOLD Nasdaq
  • Market Cap
  • HWKN 2.5B
  • FOLD 2.9B
  • IPO Year
  • HWKN N/A
  • FOLD 2007
  • Fundamental
  • Price
  • HWKN $124.50
  • FOLD $7.35
  • Analyst Decision
  • HWKN Strong Buy
  • FOLD Strong Buy
  • Analyst Count
  • HWKN 1
  • FOLD 9
  • Target Price
  • HWKN $160.00
  • FOLD $17.00
  • AVG Volume (30 Days)
  • HWKN 108.3K
  • FOLD 4.0M
  • Earning Date
  • HWKN 05-14-2025
  • FOLD 05-01-2025
  • Dividend Yield
  • HWKN 0.58%
  • FOLD N/A
  • EPS Growth
  • HWKN 12.32
  • FOLD N/A
  • EPS
  • HWKN 3.91
  • FOLD N/A
  • Revenue
  • HWKN $952,133,000.00
  • FOLD $528,294,999.00
  • Revenue This Year
  • HWKN $6.35
  • FOLD $21.83
  • Revenue Next Year
  • HWKN $5.77
  • FOLD $22.16
  • P/E Ratio
  • HWKN $32.11
  • FOLD N/A
  • Revenue Growth
  • HWKN 3.01
  • FOLD 32.29
  • 52 Week Low
  • HWKN $71.98
  • FOLD $6.20
  • 52 Week High
  • HWKN $139.55
  • FOLD $12.65
  • Technical
  • Relative Strength Index (RSI)
  • HWKN 66.04
  • FOLD 46.28
  • Support Level
  • HWKN $120.61
  • FOLD $6.63
  • Resistance Level
  • HWKN $127.00
  • FOLD $7.25
  • Average True Range (ATR)
  • HWKN 5.93
  • FOLD 0.40
  • MACD
  • HWKN 1.08
  • FOLD 0.11
  • Stochastic Oscillator
  • HWKN 90.11
  • FOLD 85.82

About HWKN Hawkins Inc.

Hawkins Inc manufactures and sells a variety of chemicals and ingredients. The firm organizes itself into three segments based on the product type. The industrial segment, which generates the majority of revenue, sells private label bleach, caustic soda, sulfuric acid, hydrochloric acid, phosphoric acid, potassium hydroxide, and aqua ammonia. The water treatment segment sells chemicals and equipment used to treat potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. The health and nutrition segment sells ingredients to food, beverage, personal care, and dietary supplement producers.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: